Acute mountain sickness
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. The subject is at an altitude of >= 3000m during the test; 2. The subject has not arrived on the plateau for more than 48 hours; 3. l LLSS score >= 3 and at least 1 headache; 4. Age >= 18 years and < 65 years; 5. No experience of living and working in a plateau within 2 months; 6. Not having participated in another clinical trial within 3 months; 7. Voluntary participation in this study and signed informed consent.
Exclusion criteria
Exclusion criteria: 1. 2 weeks before entering the plateau with dizziness, chronic headache, cardiovascular and cerebrovascular diseases, chronic respiratory diseases, chronic digestive system diseases; 2.combined with other serious diseases such as malignant tumors and mental illnesses and other diseases that affect the evaluation of this study; 3.Those who are contraindicated to electro-snap needling: such as those who have cardiac pacemakers; 4. taking preventive drugs (including acetazolamide, dexamethasone, nifedipine and phosphodiesterase-3 inhibitors) within 2 weeks before plateauing.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of AMS; | — |
Secondary
| Measure | Time frame |
|---|---|
| Bp;Oxygen saturation;Microcirculation indicators;VAS of headache;HR;the severity of AMS;GSQS;SSS;LLSS;AMS clinical function score; | — |
Countries
China
Contacts
Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences